Paul Knight
Stock Analyst at Keybanc
(2.41)
# 2,552
Out of 5,005 analysts
137
Total ratings
47.79%
Success rate
-1.43%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $6.98 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $133.22 | +65.14% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $9.68 | +54.96% | 9 | Aug 6, 2025 | |
| XGN Exagen | Upgrades: Overweight | $17 | $10.96 | +55.11% | 6 | Jul 30, 2025 | |
| EHC Encompass Health | Maintains: Overweight | $122 → $135 | $123.23 | +9.55% | 1 | May 27, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.45 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $62.95 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $328.39 | +40.08% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.34 | - | 2 | Feb 27, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $470 → $325 | $272.56 | +19.24% | 11 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $3.79 | +111.08% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $94.05 | +54.17% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $175.59 | +139.19% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $103.05 | +123.19% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $26.59 | +24.11% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $22.72 | +58.45% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $214.99 | +44.19% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $148.73 | +47.92% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $543.32 | - | 6 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $25.98 | +42.42% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.09 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $5.64 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $141.64 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $32.45 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $14.29 | +179.92% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $177.33 | +69.18% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $206.63 | +20.99% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $130.90 | +236.90% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $122.07 | +93.33% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $70.46 | +40.51% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $11.79 | +366.50% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $36.00 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $73.27 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $102.12 | - | 5 | Oct 23, 2017 |
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $6.98
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $133.22
Upside: +65.14%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $9.68
Upside: +54.96%
Exagen
Jul 30, 2025
Upgrades: Overweight
Price Target: $17
Current: $10.96
Upside: +55.11%
Encompass Health
May 27, 2025
Maintains: Overweight
Price Target: $122 → $135
Current: $123.23
Upside: +9.55%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.45
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $62.95
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $328.39
Upside: +40.08%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.34
Upside: -
West Pharmaceutical Services
Feb 14, 2025
Maintains: Overweight
Price Target: $470 → $325
Current: $272.56
Upside: +19.24%
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $3.79
Upside: +111.08%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $94.05
Upside: +54.17%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $175.59
Upside: +139.19%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $103.05
Upside: +123.19%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $26.59
Upside: +24.11%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $22.72
Upside: +58.45%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $214.99
Upside: +44.19%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $148.73
Upside: +47.92%
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $543.32
Upside: -
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $25.98
Upside: +42.42%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.09
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $5.64
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $141.64
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $32.45
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $14.29
Upside: +179.92%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $177.33
Upside: +69.18%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $206.63
Upside: +20.99%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $130.90
Upside: +236.90%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $122.07
Upside: +93.33%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $70.46
Upside: +40.51%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $11.79
Upside: +366.50%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $36.00
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $73.27
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $102.12
Upside: -